연구보고서 RSS 설명 www.khidi.or.kr ko COPYRIGHT 2015 KOREA HEALTH INDUSTRY DEVELOPMENT INSTITUTE. ALL RIGHTS RESERVED. www.khidi.or.kr <![CDATA[2017년 디지털헬스케어 진출 지원사업 보고서]]> 한국보건산업진흥원에서 발간한 "2017년 디지털헬스케어 진출 지원사업 보고서" 입니다.

제1장 개요 / 1
1. 배경 및 목적 ·················································································· 1
2. 내용 ································································································· 2
제2장 디지털헬스케어 개요 / 3
1. 디지털헬스케어 정의 ································································· 3
2. 디지털헬스케어 분류 ·································································· 8
3. 디지털헬스케어 향후 전망 ························································ 9
제3장 국내 디지털헬스케어 현황 / 20
1. 개요 ································································································· 20
2. 디지털헬스케어 서비스 사례 분석(국내 시범사업 중심) ···21
3. 디지털헬스케어 기업 현황 ························································ 38
4. 디지털헬스케어 법⋅제도 현황 ··················································· 41
5. 소결 ··································································································· 47

제4장 국외 디지털헬스케어 현황 / 49

제5장 디지털헬스케어 활성화 전략 / 332
1. 국내 디지털헬스케어 활성화 ···················································332
2. 국외 디지털헬스케어 진출 활성화 ········································ 334
부록 / 343



]]>
<![CDATA[2018년 의약품 해외시장 진출을 위한 인허가 및 시장정보(독일)]]> 한국보건산업진흥원에서 발간한 "2018년 의약품 해외시장 진출을 위한 인허가 및 시장정보(독일)" 보고서 입니다.


<차례>


제1장 기획개요 / 1

제2장 의약품 시장 동향 / 6

제3장 의약품 정책 동향 / 25

제4장 독일 의약품 규제 일반 / 33

제5장 판매 및 유통, 약가관리, 약물감시 / 112


]]>
<![CDATA[2018년 외국인환자 만족도 조사 결과보고서]]> 한국보건산업진흥원에서 발간한 "2018년 외국인환자 만족도 조사 결과보고서" 입니다.


-목차-

제1장 조사 개요

제2장 조사 결과 요약

제3장 의료서비스 결과 분석

제4장 관광서비스 결과 분석

별첨. 설문지

]]>
<![CDATA[KHIDI 바이오헬스 리포트]]>

한국보건산업진흥원에서 발간한 "KHIDI 바이오헬스 리포트" 입니다.

- 목 차 -

Focus On 보건의료 연구개발, 병원의 역할과 과제

병원 중심의 보건산업 혁신 및 활성화 방안 .................................4

보건의료 연구개발 관련 법제의 쟁점과 동향...............................11

국내 바이오클러스터 활성화를 위한 제언....................................17

Trend Watch

모바일 건강관리 서비스 시장의 현황과 미래24

북한의 보건의료 현황과 개선방안의 모색...................................31

나고야의정서 현황 및 보건산업계 대응......................................39

보건의료 서비스의 일자리 트렌드와 전망...................................44

디지털과 의료의 만남, 디지털 치료제(Digital Therapeutics).......49

Overseas Trends

Global Issues.........................................................................62

Global Conference.................................................................93

KHIDI STAT

2018년도 상반기 보건산업 통계................................................104

]]>
<![CDATA[2017 외국인환자 유치실적 통계분석보고서]]> 한국보건산업진흥원에서 발간한 "2017 외국인환자 유치실적 통계분석보고서" 입니다.


<목차>

part 01 유치사업 개요
Ⅰ. 외국인환자 유치지원 사업 근거 ···································································  2
Ⅱ. 외국인환자 유치 행위 범위 ···········································································  3
Ⅲ. 외국인환자 유치기관 등록제도 ·································································  5


part 02 2017 유치실적 조사결과
Ⅰ. 외국인환자 통계조사 개요 ···········································································  10
Ⅱ. 유치기관 조사 현황 ·······················································································  13
Ⅲ. 외국인환자 유치 현황 총괄 ··········································································  16


part 03 그래프로 보는 유치사업
Ⅰ. 외국인환자 유치기관 활동 현황 ··································································  32
Ⅱ. 의료기관 유형별 외국인환자 진료 현황 ·····················································  33
Ⅲ. 외국인환자 유치 지역별 활동 현황 ·····························································  34
Ⅳ. 외국인환자의 국가별·성별·연령별 분포 ······················································  35
Ⅴ. 외국인환자의 진료과별·질환별 분포 ···························································  37


part 04 주요 국가별 특성
Ⅰ. 중국 ··················································································································  42
Ⅱ. 미국 ··················································································································  47
Ⅲ. 일본 ··················································································································  54
Ⅳ. 러시아 ··············································································································  59
Ⅴ. 몽골 ··················································································································  64
Ⅵ. 동남아시아 ······································································································  69
Ⅶ. 중앙아시아 ······································································································  75
Ⅷ. 중동 ··················································································································  81


part 05 의료이용 유형별 특성
Ⅰ. 의료기관 유형별 현황 ···················································································  88
Ⅱ. 의료기관 소재지별 현황 ···············································································  98


part 06 부록

]]>
<![CDATA[알기 쉬운 의료기관 해외진출 과실송금 안내서(베트남/UAE/중국)]]> 한국보건산업진흥원에서 발간한 "알기 쉬운 의료기관 해외진출 과실송금 안내서" 입니다.


알기 쉬운 의료기관 해외진출 과실송금 안내서(베트남)

1. 국가 개황 ···························································································································· 1

2. 의료기관 해외진출 ············································································································ 1

3. 베트남의 외국인 투자 진출방식 ····················································································· 9

4. 설립방식별 절차 ············································································································ 15

5. 근원거래 ··························································································································· 42

6. 외환관리제도 ···················································································································· 65

7. 조세제도 및 과실송금 ···································································································· 67

8. 지분양도 및 법인청산 ·································································································· 120

9. 투자분쟁해결절차 ·········································································································· 129


알기 쉬운 의료기관 해외진출 과실송금 안내서(UAE)

1. 국가 개황 ···························································································································· 1

2. 의료기관 해외진출 ············································································································ 6

3. UAE의 외국인 투자 진출방식 ······················································································ 14

4. 설립방식별 절차 ············································································································ 34

5. 근원거래 ··························································································································· 67

6. 외환 및 금융제도 ············································································································ 82

7. 조세제도 및 과실송금 ···································································································· 87

8. 지분양도 및 법인청산 ·································································································· 128

9. 투자분쟁해결절차 ·········································································································· 136


알기 쉬운 의료기관 해외진출 과실송금 안내서(중국)

1. 국가 개황 ···························································································································· 1

2. 의료기관 해외진출 ············································································································ 6

3. 중국의 외국인 투자진출 방식 ······················································································ 14

4. 설립방식별 절차 ············································································································ 34

5. 근원거래 ··························································································································· 61

6. 외환관리제도 ················································································································· 87

7. 조세제도 및 과실송금 ···································································································· 92

8. 법인청산(지분양도) ······································································································· 159

9. 투자분쟁해결절차 ·········································································································· 182





]]>
<![CDATA[2018 중국 진출전략 -단계별 및 사례분석 중심]]>

◈중국 보건의료시장 현황


1. 중국진출을 위한 한국과 중국 관련 법률 고찰

2. 의료 해외진출 금융 및 투자유치 구조

3. 중국 진출 계획 수립의 주요사항 점검 및 사례 소개

4. 중국 의료시장 분석을 통한 중국 의료특구 진출방안 도출

5. 중국 칭다오 종합병원 운영현황 분석 및 의료기관 설립 법률 검토

6. 중국 재활의료시장과 대한민국 의료기관과의 관계에 대한 小考

7. 한국 의료기관의 중국 진출유형별 사례분석을 통한 위험요소 점검

]]>
<![CDATA[UAE 의료보험 체계분석 연구 - 규범, 행위자 및 프로세스를 중심으로 –]]>

한국보건산업진흥원에서 발간한 'UAE 의료보험 체계분석 연구'보고서 입니다.



<목차>

I. 과업 배경 및 목적

II. 연구방법

III. UAE 지역 의료보험 정책 및 법규, 규제 및 감독 기관

IV. 공공 및 민간 의료보험 제도

V. 의료비 청구 및 진료비 지급 제도

VI. 의료수가 및 보험 계약, 보험료 청구 절차

VII. 주요국 대비 UAE 의 진료 수가 수준

VIII. 결론 및 제언

]]>
<![CDATA[2018년 1분기 보건산업 고용동향]]> 한국보건산업진흥원에서 발간한 '2018년 1분기 보건산업 고용동향'보고서 입니다.

 

<목차>

제1장  총괄 / 2

제2장  세부산업별 고용동향 분석

- 의료서비스 / 4

- 의약품 / 7

- 의료기기 / 10

- 화장품 / 13

]]>
<![CDATA[최신 보건의료 빅데이터 법제 동향 조사분석]]> 한국보건산업진흥원에서 발간한 "최신 보건의료 빅데이터 법제 동향 조사분석" 연구보고서 입니다.


<차례>

제1장 서론 / 1

제2장 보건의료 빅데이터 법제 개요 / 4

제3장 유용성의 근거에 관한 최신논의 / 28

제4장 비식별화 최신동향 / 50

제5장 동의원칙의 변화 동향 / 63

제6장 법률 제․개정 최신 동향 / 72

제7장 시민 참여형 보건의료 빅데이터 조성에 관한 논의 / 116

제8장 결론 / 179



]]>